Project cooperationUpdated on 22 January 2026
Clinical collaboration for thyroid cancer and thyroid disease biospecimen collection
Associate Professor of Surgery, University of Cagliari at University of Cagliari
Cagliari, Italy
About
Our clinical unit is available to collaborate within a Horizon project by providing access to surgical thyroid specimens and associated biological materials from patients undergoing surgery for thyroid cancer and other thyroid pathologies. We routinely perform around 400 thyroidectomies annually, ensuring a stable recruitment base and consistent availability of samples across a broad spectrum of thyroid conditions.
Within a project framework, we can:
-
Collect surgical thyroid tissue specimens generated during standard-of-care procedures (e.g., tumor and non-tumor tissue, when applicable).
-
Collect and provide additional biological samples as defined by the protocol (e.g., blood-derived samples or other biospecimens, depending on study needs and feasibility).
-
Process, store, and prepare samples for transfer, and ship biospecimens to project partners, in accordance with agreed SOPs and applicable ethical/legal requirements.
-
Support clinical annotation of samples (e.g., basic demographics, diagnosis, surgical details, pathology results, outcomes), subject to approvals and data governance.
This cooperation is intended for partners seeking clinically sourced biospecimens to enable translational research, biomarker discovery/validation, molecular profiling, or the development of diagnostic/prognostic tools in thyroid oncology and thyroid disease. Sample types, handling requirements, timelines, and data fields can be aligned to the consortium protocol.
Topic
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
Type
- Offering Expertise to Consortias
Organisation
Similar opportunities
Project cooperation
Computationally Designed Tumor-Selective Antibodies & ADCs for Precision Oncology
- Offering Expertise to Consortias
- Design - setting the project scope
- Ideation - identifying the project idea
- Drafting - writing the project proposal
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Philipe Gobeil
Founder, President, CSO at 9Bio Therapeutics
Quebec, Canada
Project cooperation
Vascular Biology and Tumor Microenvironment Expertise for Translational Cancer Projects
- Completing the consortia
- Offering Expertise to Consortias
- Design - setting the project scope
- Ideation - identifying the project idea
- Drafting - writing the project proposal
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Melissa Garcia Caballero
Distinguished Researcher /Associate Professor/ Principal Investigator at University of Málaga - IBIMA.BIONAND Platform
Málaga, Spain
Project cooperation
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Lidia Castro
Pre-award project manager at Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Barcelona, Spain